Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring

Archives of Surgery

Volumn 134, Issue 7, 1999, Pages 699-705

  Thompson, Geoffrey B ^a   Grant, Clive S ^a   Perrier, Nancy D ^a   Harman, Richard ^a   Hodgson, Stephen F ^a   Ilstrup, Duane ^a   Van Heerden, Jon A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HUMAN; HYPERCALCEMIA; HYPOPARATHYROIDISM; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID SCINTISCANNING; POSTOPERATIVE COMPLICATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT LARYNGEAL NERVE PALSY; REOPERATION; SCHOOL CHILD; SURGICAL MORTALITY; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PARATHYROID HORMONE; RADIOPHARMACEUTICALS; REOPERATION; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI;

EID: 0033044922     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.7.699     Document Type: Article

References (21)

1. van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg. 1991;15:688-692.
2. Grant CS, van Heerden JA, Charboneau JW, et al. Clinical management of persistent and/or recurrent primary hyperparathyroidism. World J Surg. 1986;10: 555-565.
3. Brennan MF, Norton JA. Reoperation for persistent and recurrent hyperparathyroidism. Ann Surg. 1985;201:40-44.
4. Collins REC. Tc-99m-sestamibi - a new agent for parathyroid imaging. Nucl Med Commun. 1989;10:791-794.
5. Irvin GL, Dembrow VD, Prudhomme DL. Clinical usefulness of an intraoperative "quick parathyroid hormone" assay. Surgery. 1993;114:1019-1023.
6. Thompson GB, Mullan BP, Grant CS, et al. Parathyroid imaging with technetium-99m-sestamibi: an initial institutional experience. Surgery. 1994;116:966-973.
7. Kao PC, van Heerden JA, Taylor RL. Intraoperative monitoring of parathyroid procedures by a 15-minute parathyroid hormone immunochemiluminometric assay. Mayo Clin Proc. 1994;69:532-537.
8. McHenry CR, Pollard A, Walfish PG, Rosen IB. Intraoperative parathormone level measurement in the management of hyperparathyroidism. Surgery. 1990;108: 801-808.
9. Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang C-A. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery. 1988;104:1121-1127.
10. Peeler BB, Martin WH, Sandler MP, Goldstein RE. Sestamibi parathyroid scanning and preoperative localization studies for patients with recurrent/persistent hyperparathyroidism or significant comorbid conditions: development of an optimal localization strategy. Am Surg. 1997;63:37-46.
11. Sarfati E, Billotey C, Halimi B, Fritsch S, Cattan P, Dubost C. Early localization and reoperation for persistent primary hyperparathyroidism. Br J Surg. 1997; 84:98-100.
12. Neumann DR, Esselstyn CB Jr, Kim EY, Go RT, Obuchowski NA, Rice TW. Preliminary experience with double-phase SPECT using Tc-99m-sestamibi in patients with hyperparathyroidism. Clin Nucl Med. 1997;22:217-221.
13. Weber CJ, Vansant J, Alazraki N, et al. Value of technetium-99m-sestamibi iodine 123 imaging in reoperative parathyroid surgery. Surgery. 1993;114:1011-1018.
14. Hindie E, Melliere D, Simon D, et al. Primary hyperparathyroidism: is technetium 99m sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab. 1995;80:302-307.
15. Fayet P, Hoeffel C, Fulla Y, et al. Technetium-99-m-sestamibi scintigraphy, magnetic resonance imaging and venous blood sampling in persistent and recurrent hyperparathyroidism. Br J Radiol. 1997;70:459-464.
16. Numerow LM, Morita ET, Clark OH, Higgins CB. Persistent/recurrent hyperparathyroidism: a comparison of sestamibi scintigraphy, MRI, and ultrasonography. J Magn Reson Imaging. 1995;5:702-708.
17. Norman J, Chheda H, Farrell C. Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results. Am Surg. 1998;64:391-396.
18. Wadstrom C, Zedenius J, Guinea A, Reeve TS, Delbridge L. Re-operative surgery for recurrent or persistent primary hyperparathyroidism. Aust N Z J Surg. 1998;68:103-107.
19. Sfakianakis GN, Irvin GL, Foss J, et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med. 1996;37:798-804,
20. Harness JK, Organ CH Jr, Thompson NW. Operative experience of US general surgery residents in thyroid and parathyroid disease. Surgery. 1995;118:1063-1069.
21. Pattou F, Oudar C, Huglo D, et al. Localization of abnormal parathyroid glands with jugular sampling for parathyroid hormone, and subtraction scanning with sestamibi or Tetrofosmine. Aust N Z J Surg. 1998;68:108-111.